FDA.reportPublic FDA data

tobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension

RxCUI
849115
RxNorm name
tobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension
Display name
tobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension
Full name
tobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Tobradex STTOBRAMYCIN / DEXAMETHASONEHarrow Eye, LLC3b99dbb3-ac84-4d0d-b30f-a5db44fdc3162025-04-01Warnings, Adverse reactionsExact identifier
rxcui: 849115
Tobradex STTOBRAMYCIN / DEXAMETHASONEEyevance Pharmaceuticals, LLCc2d7325e-4f58-5590-e053-2a95a90ace1b2025-01-16Warnings, Adverse reactionsExact identifier
rxcui: 849115

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
c2d7325e-4f58-5590-e053-2a95a90ace1btobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension [PSN] · dexamethasone 0.5 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension [SCD] · dexamethasone 0.05 % / tobramycin 0.3 % Ophthalmic Suspension [SY]39HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TOBRADEX ST safely and effectively. See full prescribing information for TOBRADEX ST. TOBRADEX ST (tobramycin and dexamethasone ophthalmic suspension) 0.3%/0.05%, for topical ophthalmic use Initial U.S. Approval: 198820250116
3b99dbb3-ac84-4d0d-b30f-a5db44fdc316tobramycin 0.3 % / dexAMETHasone 0.05 % Ophthalmic Suspension [PSN] · dexamethasone 0.5 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension [SCD] · dexamethasone 0.05 % / tobramycin 0.3 % Ophthalmic Suspension [SY]33These highlights do not include all the information needed to use TOBRADEX ST safely and effectively. See full prescribing information for TOBRADEX ST. TOBRADEX ® ST (tobramycin and dexamethasone ophthalmic suspension) 0.3%/0.05%, for topical ophthalmic use Initial U.S. Approval: 198820250401